Techpool Bio-pharma Co aims to become a leader in protein production

The company, located in Guangzhou’s Nansha District, has invested 180 million Yuan for a protein proeduction facility which can handle 15.000 t/year. The company features the production of proteins from urine, e. g., Kailikang, a human protease which dilates arteries and inhibits platelet aggregation.

China Bio news release, June 25, 2015

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny